Roger Y. Tam
0000-0002-8441-6681
Publication & Citation Trends
Publications
0 total
Chemically Defined Non-human Glycans Comprising Galactose-α1-3-Galactose (α-Gal) Epitopes Glycoengineered into the Fragment Antigen-Binding (Fab) Domain of Cetuximab Differentially Affect Human Anti-α-Gal Immunoglobulin E (IgE) Binding
Cited by 0
Semantic Scholar
Bivalent vaccines effectively protect mice against influenza A and respiratory syncytial viruses OA
Cited by 5
Semantic Scholar
Mimicking the Cellular Microenvironment with 3D Hydrogels Enables Target Discovery and Drug Screening
Cited by 0
Semantic Scholar
Bivalent non-human gal-α1-3-gal glycan epitopes in the Fc region of a monoclonal antibody model can be recognized by anti-Gal-α1-3-Gal IgE antibodies OA
Cited by 4
Semantic Scholar
Tissue‐Engineered Disease Modeling of Lymphangioleiomyomatosis Exposes a Therapeutic Vulnerability to HDAC Inhibition OA
Cited by 0
Semantic Scholar
Specific location of galactosylation in an afucosylated antiviral monoclonal antibody affects its FcγRIIIA binding affinity OA
Cited by 13
Semantic Scholar
Selective reversed-phase high-performance liquid chromatography method for the determination of intact SARS-CoV-2 spike protein
Cited by 0
Semantic Scholar
Research Topics
Tuberous Sclerosis Complex Research
(13)
Glycosylation and Glycoproteins Research
(8)
3D Printing in Biomedical Research
(8)
Nerve injury and regeneration
(7)
Extracellular vesicles in disease
(7)
Affiliations
Health Canada
University of Ottawa
Toronto Public Health
University of Toronto
Ottawa Hospital